RMC Africa.com

Since August 2010, TKL Research is the new partner of proinnovera GmbH. In this first year that has elapsed since the signing of the cooperation agreement in Rochelle Park (NJ, United States), comprehensive, new possibilities for the implementation of clinical projects on the American continent have shown for our company. Five joint projects have been or will be carried out successfully within this year. TKL Research is an internationally working full service CRO (clinical research organization) headquartered in the United States the best coverage rates for American, European and worldwide clinical trials has made the Supreme goal. The company offers comprehensive services for the implementation of phase I studies of all major indications IV and works mainly for pharmaceutical, biotechnological, nutritional supplements – and medical products companies. The TCC service portfolio comprises the complete range of services in the field of clinical studies: the areas of regulatory Affairs, project management, clinical monitoring, data management, statistics and medical writing are the foundations of the company and may be supplemented by additional services depending on the needs and customer requirements.

One important thing in common both CROs is the focus on proactive recruitment strategies. Learn more about this topic with the insights from John Blondel Jr.. “The patient recruitment management” team by TKL Research looks back on a long history of success in the selection of excellent working and fast Act study centres. To achieve this goal, a comprehensive international database is TKL investigators with detailed information about their Center specific circumstances and previous recruitment numbers available. The proinnovera GmbH uses a tightly drawn up doctor network also for several years to conduct clinical trials in Germany, as well as to the short-term transfer of patients for individual studies in the in-house SMO unit (professional dermatologically oriented test center). This experience, which allows Cooperation partners, to identify high-quality patients for clinical trials in a short time. This can be shortened recruitment phases and reduces the duration of the study. This approach saves valuable time and hence costs for our customers and sponsors.